期刊文献+

盐酸苯达莫司汀致药疹1例 被引量:1

下载PDF
导出
摘要 1临床资料 患者女,63岁。双上眼睑反复水肿2个月余,全身皮疹伴痒2个月就诊。患者诉2个月前因“慢性淋巴细胞白血病(CLL)”使用“盐酸苯达莫司汀”治疗2个疗程第28天(1个疗程为28天)出现双上眼睑水肿,伴恶心,无呕吐,未重视,
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第9期981-982,共2页 The Chinese Journal of Dermatovenereology
  • 相关文献

参考文献8

  • 1任健,程卯生.盐酸苯达莫司汀(bendamustine hydrochloride)[J].中国药物化学杂志,2008,18(5):399-399. 被引量:8
  • 2邢立杰(综述),李增军(审校),邱录贵(审校).苯达莫司汀在淋巴肿瘤中的应用进展[J].国际输血及血液学杂志,2011,34(1):24-27. 被引量:4
  • 3Alamdari HS,Pinter-Brown L,Cassarino DS,et ',tl. Severe cutaneous in- ter -face drug eruption associated with bendamustine [ J ]. Dernmtolo~" Online Jourrm] ,201 O, 16 ( 7 ) : 1.
  • 4Gavini A, Telang GH, Olszewski AJ. Generalized purpuric drug exan- them with hemor/'hagi~' plaques following bendamustinechemotherapy in a patient with B-prolymphocytie leukemia[ J]. Int J Hematol,2012,95 (3) :31I -314.
  • 5lxunbertini M,Del Mastro L,Gartlin G,et al. Stevens-Johnson syndrome after treatment with bendamustine [ J ]. l.euk Res, 2012,36 ( 7 ) : e153- 154.
  • 6Mahmoud BH, Eide MJ. Bendamustine-induced "tlagellate dermatitis" [J]. Dermatol Online J,2012,18( 11 ) : 12.
  • 7Castegnaro S,Visco C,Chieregato K,et al. Cytosine m'abinnside potenti- ates the apoptotic effect of bcndamustine on several B- and T-cell leuke- mia/lymphoma cells and cell lines [ J ]. Leuk Lymphnma, 2012,53 ( 11 ) :2262 -2268.
  • 8徐艳萍,方洪元,纪岩文.药疹151例临床分析[J].中国皮肤性病学杂志,2009,23(3):158-159. 被引量:15

二级参考文献27

  • 1刘纯卉,曹莉,王侠生.丙种球蛋白联合甲泼尼龙治疗重症大疱型药疹16例临床分析[J].中国皮肤性病学杂志,2007,21(2):102-102. 被引量:9
  • 2BREMER K, ROTH W. Bendamustine, a low toxic nitrogen-mustard derivative with high efficacy in malignant lymphomas [J] .Tumor Diagn Ther, 1996,17(1) : 1 - 6.
  • 3JULIA A B B, KAREN L G. Bendamustine[J]. Drugs, 2001, 61(5) :631 - 638.
  • 4HOFFKEN K, MERKLE K, SCHONFELDER M, et al. Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase Ⅱ study[J ]. J Cancer Res Clin Oneol, 1998,124(11) :627 - 632.
  • 5PONISCH W, MITROU P S, MERKLE K, et al. A randomized multicenter study of bendamustine/prednisone versus melphalane/prednisone in the primary treatment of multiple myeloma[J]. Blood, 1999, 94(10, Suppl. 1) : 123a.
  • 6NASSER M, BITTERMAN-DEUTSCH O, NASSAR F. Intravenous immunoglobulin for treatment of toxic epidermal necrolysis[J]. Am J Med Sci,2005,329 (2) :95 - 98.
  • 7Knauf WU,Lissichkov T,Aldaoud A,et al.Bendamustin eversus chlorambucil in treatment-naive patients with B-cell chronic lymphocytic leukemia (B-CLL):re-sults of an international phase Ⅲ study.Blood (ASH Annual Meeting Abstracts),2007,110:2043.
  • 8Knauf WU,Lissichkov T,Aldaoud A,et al.Phase Ⅲ Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia.J Clin Oncol,2009,27 (26):4378-4384.
  • 9Knauf WU,Lissichkov T,Aldaoud A,et al.Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.Blood (ASH Annual Meeting Abstracts),2009,114:2367.
  • 10Weide R,Pandorf A,Heymanns J,et al.Bendamustine/mitoxantrone/rituxi-mab (BMR):A very effective,well tolerated outpatient chemoimmunotherapy for relapsed and refractory CD20-positive indolent malignancies Final results of a pilot study.Leuk Lymphoma,2004,45 (12):2445-2449.

共引文献24

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部